Related Experiment Video

Updated: Jun 29, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

704

Pathogenetic justification of digestive tract dysfunction correction to reduce the risk of ventricular extrasystoles

Timur Utegaliev1, Marshan Ermakhanova2, Bauyrzhan Sarsembayev3

  • 1Department of Interventional Cardiology, Mangystau Regional Multidisciplinary Hospital, Aktau, Republic of Kazakhstan.

Przeglad Gastroenterologiczny
|April 4, 2024
PubMed

Insights

Correcting digestive tract dysfunction after coronary artery bypass grafting (CABG) significantly reduced intestinal paresis and ventricular extrasystoles. This intervention improves patient outcomes following cardiac surgery.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Surgical Pathology

Background:

  • Abdominal pathology is frequently observed in heart disease patients but often overlooked.
  • Lack of established protocols for managing endothelial dysfunction post-coronary artery bypass grafting (CABG) using artificial circulation (AC).

Purpose of the Study:

  • To validate the pathogenetic rationale for addressing postoperative intestinal paresis after CABG.
  • To prevent functional cardiac complications by correcting digestive tract dysfunction.

Main Methods:

  • 147 male patients undergoing CABG were divided into two groups.
  • Statistical analysis using Microsoft Excel, parametric methods, and Student's t-test.

Main Results:

  • Group II, receiving intervention, showed significantly fewer intestinal dysfunction symptoms (p=0.019) and faster bowel function recovery (p=0.033) compared to Group I.
  • The incidence of high-grade ventricular extrasystoles was significantly lower in Group II post-CABG (p=0.033).

Conclusions:

  • Implementing a digestive tract dysfunction correction program is pathogenetically sound.
  • This program reduces intestinal paresis, consequently lowering the occurrence of high-grade ventricular extrasystoles after CABG.
Abstract

Keywords:
cardiac-enteral inhibitory reflexcoronary artery bypass graftingintestinal dysfunctionpermanent blockadeventricular extrasystole

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.4K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.5K

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
950
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
918
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578